Who are the peers of the Medinova Diagno.?
Peers of Medinova Diagno. include Syngene Intl., Dr Lal Pathlabs, Poly Medicure, and others. Dr Lal Pathlabs shows excellent management and growth, while Poly Medicure has the highest 1-year return at 24.17%, compared to Medinova Diagno.'s 9.98%.
Peers: The peers of Medinova Diagno. are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., GKB Ophthalmics, Amkay Products, Transgene Biotek, Shree Pacetronix, and Samsrita Labs.Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, Vijaya Diagnost., Amkay Products, and Shree Pacetronix, and the rest have Below Average or do not qualify. Growth ratings show that Dr Lal Pathlabs has Excellent growth, while Average growth is noted at Poly Medicure, Indegene, and the rest, with Below Average growth at Syngene Intl., Vijaya Diagnost., Amkay Products, GKB Ophthalmics, and the rest. All peers except Medinova Diagno. and Transgene Biotek have Excellent capital structure, while GKB Ophthalmics has Good, and Amkay Products has Average.
Return Snapshot: The peer with the highest 1-year return is Poly Medicure at 24.17%, while the lowest is Amkay Products at -34.33%. Medinova Diagno. has a 1-year return of 9.98%, which is higher than Amkay Products but lower than Poly Medicure. Additionally, the six-month return is negative for Syngene Intl., Amkay Products, Transgene Biotek, and Shree Pacetronix.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
